OBJECTIVE: Carney complex (CNC) is an autosomal dominant multiple neoplasia syndrome featuring cardiac, endocrine, cutaneous and neural tumours, as well as a variety of pigmented lesions of the skin and mucosa. Pituitary GH-secreting tumours are found in approximately 10% of patients with CNC. One of the genes responsible for CNC, the PRKAR1A gene located on human chromosome 17q22-24, has recently been cloned. This represents a putative tumour suppressor gene, coding for the type 1alpha regulatory subunit of protein kinase A (PKA), which is found to be mutated in approximately half of the patients with CNC. However, it is currently unclear as to whether similar mutations occur in sporadic pituitary tumours. We have therefore investigated a ...
The genesis of pituitary tumours is still under debate. Although these neoplasias are monoclonal in ...
The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas i...
CONTEXT: Alterations in the cAMP signalling pathway are common in hormonally-active endocrine tumors...
Objective: The objective was to assess involvement of loss of the PRKAR1A gene encoding a type 1α re...
(Correspondence should be addressed to A B Grossman) Objective: Multiple endocrine neoplasia type 1 ...
OBJECTIVE: Multiple endocrine neoplasia type 1 (MEN 1) is an autosomal dominant inherited disorder c...
Heterozygous loss of function mutations in human PKARlA gene (PRKARlA) have been identified in patie...
OBJECTIVE: The pathogenetic mechanisms of sporadic somatotroph adenomas are not well understood, but...
Context: The tumorigenic role of genetic abnormalities in sporadic pituitary nonfunctioning adenomas...
OBJECTIVE: Most pituitary tumours occur sporadically without a genetically identifiable germline abn...
Background: Carney complex (CNC) is a familial multiple neoplasia syndrome frequently associated wit...
Pituitary adenomas are one of the most frequent intracranial tumors with a prevalence of clinically-...
Context: Alterations in the cAMP signaling pathway are common in hormonally active endocrine tumors....
Context: Limited screening suggests that three germline mutations in the aryl hydrocarbon receptor i...
© 2017 Neurology India, Neurological Society of India. Clinically relevant pituitary tumors presenti...
The genesis of pituitary tumours is still under debate. Although these neoplasias are monoclonal in ...
The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas i...
CONTEXT: Alterations in the cAMP signalling pathway are common in hormonally-active endocrine tumors...
Objective: The objective was to assess involvement of loss of the PRKAR1A gene encoding a type 1α re...
(Correspondence should be addressed to A B Grossman) Objective: Multiple endocrine neoplasia type 1 ...
OBJECTIVE: Multiple endocrine neoplasia type 1 (MEN 1) is an autosomal dominant inherited disorder c...
Heterozygous loss of function mutations in human PKARlA gene (PRKARlA) have been identified in patie...
OBJECTIVE: The pathogenetic mechanisms of sporadic somatotroph adenomas are not well understood, but...
Context: The tumorigenic role of genetic abnormalities in sporadic pituitary nonfunctioning adenomas...
OBJECTIVE: Most pituitary tumours occur sporadically without a genetically identifiable germline abn...
Background: Carney complex (CNC) is a familial multiple neoplasia syndrome frequently associated wit...
Pituitary adenomas are one of the most frequent intracranial tumors with a prevalence of clinically-...
Context: Alterations in the cAMP signaling pathway are common in hormonally active endocrine tumors....
Context: Limited screening suggests that three germline mutations in the aryl hydrocarbon receptor i...
© 2017 Neurology India, Neurological Society of India. Clinically relevant pituitary tumors presenti...
The genesis of pituitary tumours is still under debate. Although these neoplasias are monoclonal in ...
The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas i...
CONTEXT: Alterations in the cAMP signalling pathway are common in hormonally-active endocrine tumors...